Search results for " organizations."

showing 10 items of 655 documents

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

2014

We assessed the cost-effectiveness of sofosbuvir (SOF)-based triple therapy (TT) compared with boceprevir (BOC)- and telaprevir (TVR)-based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source. The target population was made up of untreated Caucasian patients, aged 50 years, with G1CHC and these were evaluated over a lifetime horizon by Markov model. The study was carried out from the perspective of the Italian National Health Service. Outcomes included discounted costs (in euros at 2013 value), life-years gained (LYG), quality-adju…

medicine.medical_specialtyCirrhosisHepatologySofosbuvirCost effectivenessbusiness.industryHepatologymedicine.diseaseSurgeryQuality-adjusted life yearTelaprevirchemistry.chemical_compoundTolerabilitychemistryBoceprevirInternal medicinemedicinebusinesshealth care economics and organizationsmedicine.drugHepatology
researchProduct

Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test

2010

Objectives: The aim of this study was to compare the cost and the effectiveness of two biennial fecal occult blood screening tests for colorectal cancer: a guaiac nonrehydrated test (G-FOBT) and an immunochemical test (I-FOBT) with the absence of screening.Methods: A Markov model was developed to compare these strategies in a general population of subjects aged 50 to 74 over a 20-year period.Results: Compared with the absence of screening, G-FOBT and I-FOBT were associated with a decrease in colorectal cancer mortality of 17.4 percent and 25.2 percent, respectively. With regard to cost-effectiveness, expressed as cost per life-year gained, I-FOBT was the most effective and most costly alter…

medicine.medical_specialtyColorectal cancerCost effectivenessCost-Benefit Analysishealth care facilities manpower and serviceseducationPopulationImmunologic TestsSensitivity and SpecificityInternal medicinemedicineHumansMass ScreeningeducationSensitivity analyseshealth care economics and organizationsMass screeningAgedGynecologyeducation.field_of_studybiologybusiness.industryHealth PolicyEurosMiddle Agedmedicine.diseasebiology.organism_classificationMarkov Chainsdigestive system diseasesTest (assessment)surgical procedures operativeFecal occult blood screeningOccult BloodIndicators and ReagentsFranceColorectal NeoplasmsGuaiacbusinessInternational Journal of Technology Assessment in Health Care
researchProduct

Understanding cultural influences on back pain and back pain research

2017

Low back pain is highly prevalent and places a considerable burden on individuals, their families and communities. This back pain burden is unequally distributed around the world and within populations. Clinicians and researchers addressing back pain should be aware of the cultural, social and political context of back pain patients and how this context can influence pain perception, disability and health care use. Culture, which influences the beliefs and behaviour of individuals within a social group, could be considered an important contributor to the unequal distribution of back pain. However, there is paucity of high-quality research exploring the influence of culture on the experience…

medicine.medical_specialtyCultureEthnic groupContext (language use)Affect (psychology)Social group03 medical and health sciences0302 clinical medicineRheumatologyhealth services administrationHealth careBack painmedicineHumans030212 general & internal medicineSocial determinants of healthhealth care economics and organizationsbusiness.industryequipment and suppliesR1Low back painBack PainPhysical therapypopulation characteristicsmedicine.symptombusinessLow Back PainRAhuman activities030217 neurology & neurosurgeryClinical psychologyBest Practice & Research Clinical Rheumatology
researchProduct

Country of residence, gender equality and victim blaming attitudes about partner violence: a multilevel analysis in EU

2017

Background: Intimate partner violence against women (IPVAW) is a global and preventable public health problem. Public attitudes, such as victim-blaming, are important for our understanding of differences in the occurrence of IPVAW, as they contribute to its justification. In this paper, we focus on victim-blaming attitudes regarding IPVAW within the EU and we apply multilevel analyses to identify contextual determinants of victim-blaming attitudes. We investigate both the general contextual effect of the country and the specific association between country level of gender equality and individual victim-blaming attitudes, as well as to what extend a possible general contextual effect was exp…

medicine.medical_specialtyDiscriminatory accuracyeducationSocial SciencesPoison controlIntimate partner violence against women (IPVAW)Victim-blaming attitudesAffect (psychology)Multilevel analysis03 medical and health sciences0302 clinical medicinemedicinemedia_common.cataloged_instance030212 general & internal medicineEuropean unionhealth care economics and organizations0505 lawmedia_commonPublic health05 social sciencesMultilevel modelPublic Health Environmental and Occupational HealthSamhällsvetenskapHuman factors and ergonomicshumanitiesCountry differencesbehavior and behavior mechanisms050501 criminologyDomestic violenceResidencePsychologySocial psychologyEuropean Journal of Public Health
researchProduct

Implantable collamer lens with central hole: 3-year follow-up.

2018

Luis Fernández-Vega-Cueto,1 Carlos Lisa,1 José J Esteve-Taboada,2 Robert Montés-Micó,2 José F Alfonso1,3 1Department of Surgery, Fernández-Vega Ophthalmological Institute, Oviedo, Spain; 2Department of Optics and Optometry and Visual Sciences, University of Valencia, Valencia, Spain; 3School of Medicine, University of Oviedo, Oviedo, Spain Purpose: To evaluate the long-term predictability, stability, safety, and efficacy of the V4c Visian implantable collamer lens (ICL) with central hole to correct myopia.Patients and methods: One hundred and eighty-four eyes of 92 patients were evaluated during 3 years after implantation of …

medicine.medical_specialtyDistance visual acuitygenetic structuresVisian ICLeducationEmmetropiaSpherical equivalentPhakic intraocular lensEndothelial cell count03 medical and health sciences0302 clinical medicineOphthalmologyMedicinehealth care economics and organizationsOriginal ResearchImplantable collamer lensbusiness.industryimplantable collamer lensClinical Ophthalmologyeye diseasesOphthalmologylong-term evaluation030221 ophthalmology & optometrybusinessphakic intraocular lens030217 neurology & neurosurgeryClinical ophthalmology (Auckland, N.Z.)
researchProduct

Klinische und ökonomische Evaluation der Inanspruchnahme zahnärztlicher Leistungen im Ausland

2003

Purpose During the past decade German patients developed an increasing tendency to dental health tourism in countries outside the European Union. The present investigation aimed at evaluating both clinical and economic outcome of dental care in these countries with regard to German directive standards. Methods Based on physical examinations performed by the Medizinische Dienst der Krankenversicherung Rheinland-Pfalz in the context of reimbursement or regress requests after dental care in countries outside the European Union, an individual treatment concept was designed and its direct costs from the patient's perspective were estimated according to German standards. Furthermore, the clinical…

medicine.medical_specialtyHealth economicsbusiness.industryPublic Health Environmental and Occupational HealthMEDLINEContext (language use)Directivelanguage.human_languageGermanIndirect costsNursingFamily medicinelanguagemedicinemedia_common.cataloged_instanceEuropean unionbusinesshealth care economics and organizationsReimbursementmedia_commonDas Gesundheitswesen
researchProduct

Proposal for an Alliance Between Healthcare and Legal Area Professionals for Shared Public Health and Preventive Strategies in Italy and Europe

2020

Following the implementation of the new Italian legislation on responsibility of healthcare workers, a multi-professional framework, involving representatives of the Italian public health professionals and legal professionals expert in the field, drafted a proposal of the actionable recommendations to be implemented in the management of civil and penal disputes arising from the practice of public health interventions. In order to prevent legal disputes concerning some public health fields such as vaccinations, cancer screening, environmental health surveillance, and hospital management, it should be primary taken into account to update guidelines in supporting decision-making processes, in …

medicine.medical_specialtyLegislationSettore MED/42 - Igiene Generale E ApplicataScientific evidence03 medical and health sciencesmandatory vaccination0302 clinical medicineOrder (exchange)Multidisciplinary approachPolitical scienceHealth caremedicineHumans030212 general & internal medicinehospital managementLegal professionhealth care economics and organizationsbusiness.industry030503 health policy & servicesPublic healthlcsh:Public aspects of medicinemultidisciplinary approach healthcare disputes mandatory vaccination cancer screening environmental health surveillance hospital managementPublic Health Environmental and Occupational HealthCancer screening; Environmental health surveillance; Healthcare disputes; Hospital management; Mandatory vaccination; Multidisciplinary approachlcsh:RA1-1270Public relationshumanitiesPolicy BriefEuropeAllianceItalycancer screeninghealthcare disputesmultidisciplinary approachPublic HealthHealth Facilities0305 other medical sciencebusinessenvironmental health surveillanceDelivery of Health CareFrontiers in Public Health
researchProduct

Birth-weight differences at term are explained by placental dysfunction and not by maternal ethnicity. Study in newborns of first generation immigran…

2020

The aim of the study was to investigate the influence of ethnicity and cerebroplacental ratio (CPR) on the birth weight (BW) of first generation Indo-Pakistan immigrants' newborns.This was a retrospective study in a mixed population of 620 term Caucasian and Indo-Pakistan pregnancies, evaluated in two reference hospitals of Spain and Italy. All fetuses underwent a scan and Doppler examination within two weeks of delivery. The influence of fetal gender, ethnicity, GA at delivery, CPR, maternal age, height, weight and parity on BW was evaluated by multivariable regression analysis.Newborns of first generation Indo-Pakistan immigrants were smaller than local Caucasian newborns (mean BW mean= 3…

medicine.medical_specialtyMiddle Cerebral Arterymedia_common.quotation_subjectBirth weightPlacentaImmigrationEthnic groupEmigrants and ImmigrantsGestational AgeUltrasonography PrenatalUmbilical ArteriesPlacental dysfunctionPregnancymedicineEthnicityBirth WeightHumanshealth care economics and organizationsmedia_commonRetrospective StudiesObstetricsbusiness.industryInfant NewbornParturitionObstetrics and GynecologyFetal dopplerFirst generationTerm (time)Pediatrics Perinatology and Child Healthpopulation characteristicsFemaleFetal nutritionbusinessgeographic locationsThe journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
researchProduct

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

2016

ABSTRACT Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy. Methods: A Markov model was adapted to the Italian setting to estimate the incremental cost-effectiveness ratio (ICER) of bedaquiline plus BR (BBR) versus BR in the treatment of MDR-TB and XDR-TB over 10 years, from both the National Health Service (NHS) and societal perspective. Cost-effectiveness was evaluated in terms of life-years gained (LYG). Clinical data were sourced from trials; resource consumption for compared treatments was modelled according to advice from an expert c…

medicine.medical_specialtyPediatricsTuberculosisCost effectivenessBedaquilinelcsh:Business03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSocietal perspectivemedicineOriginal Research Article030212 general & internal medicineResource consumptionSensitivity analysescost-effectivenessDisease treatmenthealth care economics and organizationsbusiness.industrylcsh:Public aspects of medicinelcsh:RA1-1270medicine.diseaseNational health serviceMDR tuberculosis030228 respiratory systemchemistryItalyEmergency medicineXDR tuberculosisOriginal ArticleBedaquilinebusinesslcsh:HF5001-6182Journal of Market Access & Health Policy
researchProduct

A Phase 1b, Dose-Finding Study Of Ruxolitinib Plus Panobinostat In Patients With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or …

2013

Abstract Background Myelofibrosis (MF) is a myeloproliferative neoplasm associated with progressive, debilitating symptoms that impact patient quality of life (QoL) and reduce survival. Ruxolitinib (RUX), a potent dual JAK1/JAK2 inhibitor, demonstrated superiority in spleen volume and symptom reduction, improved health-related QoL measures, and prolonged survival compared with traditional therapies or placebo in the phase 3 COMFORT studies. Panobinostat (PAN) is a potent oral pan-deacetylase inhibitor (DACi) that inhibits JAK pathway signaling through increased acetylation of the JAK2 protein chaperone HSP90. In phase 1/2 studies in MF, PAN has shown reduction in splenomegaly and JAK2 V617F…

medicine.medical_specialtyRuxolitinibbusiness.industryeducationImmunologyCell BiologyHematologymedicine.diseasePlaceboOff-label useBiochemistryDiscontinuationInternational Prognostic Scoring SystemInternal medicineCohortImmunologymedicineMyelofibrosisbusinessAdverse effecthealth care economics and organizationsmedicine.drugBlood
researchProduct